respiratori
viral
infect
among
common
trigger
acut
exacerb
preschool
wheez
asthma
chronic
obstruct
pulmonari
diseas
copd
asthma
copd
sever
disabl
diseas
respiratori
tract
henc
repres
seriou
global
health
problem
affect
differ
age
group
acut
preschool
wheez
communityacquir
pneumonia
cap
common
caus
emerg
visit
possibl
viral
etiolog
increas
preval
airway
diseas
rise
treatment
cost
therefor
virusinduc
respiratori
ill
heavi
burden
patient
respiratori
viral
infect
mainli
due
rhinoviru
rv
respons
approxim
wheez
asthma
exacerb
moreov
infant
rhinovirusinduc
wheez
significantli
increas
risk
subsequ
develop
recurr
wheez
childhood
sinc
exposur
rv
lead
wheez
ill
children
addit
factor
host
genotyp
defect
respiratori
epitheli
barrier
andor
atop
predisposit
suggest
play
import
role
rv
genet
highli
divers
viru
group
distinct
rv
type
divid
three
distinct
rv
speci
rva
rvb
rhinovirus
also
classifi
accord
cellular
receptor
human
respiratori
epitheli
cell
use
rvb
rva
variant
bind
intercellular
adhes
ie
major
rv
group
subset
rva
speci
bind
lowdens
lipoprotein
receptor
ie
minor
rv
group
recent
cadherinrel
famili
member
protein
report
one
probabl
receptor
rvc
identif
culprit
rhinoviru
speci
respons
sever
exacerb
respiratori
diseas
extrem
import
topic
certain
rv
speci
eg
rvc
suspect
associ
sever
wheez
ill
acut
asthma
exacerb
infant
children
compar
fact
also
sever
prevent
therapeut
strategi
rv
infect
develop
requir
precis
knowledg
clinic
relev
rv
speci
target
exampl
sever
approach
develop
vaccin
base
polyval
inactiv
rv
synthet
rvderiv
peptid
recombin
rv
protein
formul
broadli
protect
vaccin
obvious
requir
inclus
clinic
relev
common
rv
speci
furthermor
shown
block
viral
receptor
respiratori
epitheli
cell
eg
prevent
rv
therapeut
approach
target
viral
receptor
requir
knowledg
rv
speci
frequent
relev
one
final
import
investig
role
differ
rv
speci
exacerb
sever
bronchial
obstruct
differ
popul
differ
age
group
manifest
respiratori
ill
eg
preschool
wheez
asthma
copd
asthmacopd
overlap
aco
cap
rv
well
establish
import
trigger
factor
childhood
wheez
asthma
less
known
regard
role
rv
infect
exacerb
copd
respiratori
diseas
exacerb
older
furthermor
causal
relationship
rv
cap
also
current
detect
rv
cours
respiratori
infect
mainli
base
revers
transcript
viral
rna
dna
amplif
polymeras
chain
reaction
pcr
test
demonstr
presenc
virusderiv
nucleic
acid
necessarili
indic
particular
viru
caus
infect
inde
respons
clinic
symptom
fact
rhinoviru
rna
found
high
proport
asymptomat
infant
furthermor
littl
known
level
epitopespecif
natur
antibodi
respons
capabl
neutral
rhinovirus
thu
protect
individu
rv
infect
inform
would
help
develop
new
immunolog
strategi
treatment
prevent
rvinduc
exacerb
respiratori
diseas
therefor
huge
far
unmet
need
highresolut
serolog
detect
rhinoviru
infect
previous
identifi
capsid
protein
ntermin
peptid
major
target
natur
antibodi
respons
rvinfect
demonstr
vivo
inocul
subject
inde
induc
increas
antibodi
respons
best
detect
protein
correspond
similar
increas
rvspecif
antibodi
found
preschool
children
asthma
attack
use
complet
recombin
rv
capsid
recent
studi
perform
preschool
children
acut
asthma
attack
observ
increas
rvspecif
antibodi
respons
reflect
sever
respiratori
present
studi
fund
european
union
project
predicta
http
investig
possibl
gener
microarraybas
serolog
test
discrimin
rva
rvb
rvc
culprit
speci
involv
childhood
asthma
attack
figur
show
arrang
rvderiv
protein
peptid
well
control
protein
predicta
chip
select
procedur
ntermin
peptid
recombin
capsid
protein
fragment
thereof
repres
rva
b
c
speci
well
nonstructur
protein
includ
supplementari
tabl
base
previou
find
antibodi
rvinfect
patient
react
preferenti
nterminu
ref
includ
synthet
ntermin
peptid
rv
strain
select
ration
multistep
process
repres
distinct
rv
strain
fig
supplementari
tabl
start
sequenc
retriev
ncbi
databas
rva
rvb
rvc
multipl
sequenc
align
perform
identifi
cluster
peptid
high
degre
sequenc
ident
fig
supplementari
tabl
cluster
next
step
peptid
reclust
group
take
chemic
properti
amino
acid
consider
supplementari
tabl
group
peptid
distantli
relat
sequenc
select
fig
c
supplementari
tabl
refin
antibodi
respons
fragment
well
peptid
span
complet
sequenc
includ
fig
supplementari
tabl
control
calibr
purpos
ad
recombin
allergen
control
protein
fig
supplementari
tabl
predicta
chip
protein
peptid
spot
triplic
preactiv
glass
slide
contain
six
microarray
surround
teflon
frame
one
chip
allow
test
six
serum
sampl
fig
ident
puriti
recombin
protein
peptid
test
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
follow
coomassi
brilliant
blue
stain
westernblot
mass
spectrometri
respect
supplementari
tabl
supplementari
fig
supplementari
tabl
show
predicta
microarray
allow
reproduc
measur
igg
level
antigen
accord
intra
interassay
variat
predicta
chip
test
sera
preschool
children
admit
hospit
due
acut
wheez
tabl
summar
demograph
clinic
data
children
investig
studi
investig
spectrum
recogn
rv
peptid
vari
age
children
group
accord
age
group
year
n
group
ii
year
n
group
iii
year
n
figur
b
show
frequenc
intens
igg
iga
antibodi
reactiv
children
ntermin
peptid
repres
rva
rvb
rvc
speci
frequent
highest
igg
respons
direct
rvcderiv
peptid
follow
rva
peptid
wherea
igg
reactiv
rvb
peptid
less
frequent
intens
fig
similar
result
obtain
iga
respons
gener
lower
igg
respons
fig
analysi
igg
reactiv
structur
nonstructur
protein
recombin
fragment
synthet
peptid
span
shown
supplementari
fig
children
supplementari
fig
children
n
shown
increas
antibodi
respons
followup
serum
sampl
taken
recoveri
result
obtain
thu
confirm
earlier
observ
show
major
rvspecif
antibodi
respons
direct
nterminu
repres
peptid
nterminu
protein
differ
rv
children
show
igg
respons
particular
fragment
repres
middl
portion
wherea
show
relev
igg
reactiv
supplementari
fig
b
among
nonstructur
protein
show
igg
reactiv
supplementari
fig
analysi
igg
reactiv
accord
age
children
acut
visit
show
children
year
age
much
lower
rvspecif
igg
level
compar
children
older
year
almost
chang
rv
strainspecif
pattern
among
three
age
group
fig
howev
found
posit
correl
number
recogn
peptid
age
children
fig
children
month
age
recogn
significantli
lower
number
ntermin
peptid
older
month
children
children
older
year
react
significantli
peptid
group
younger
children
fig
pattern
antibodi
respons
differ
rv
peptid
also
analyz
use
independ
bioinformat
approach
supplementari
fig
phylogenet
cluster
peptid
prepar
use
gener
peptid
group
accord
sequenc
homolog
repres
larg
extent
rv
subgroup
b
c
unsupervis
comput
algorithm
use
cluster
pattern
antibodi
respons
final
result
analys
superimpos
turn
strong
correl
two
group
one
base
antibodi
reactiv
base
sequenc
ident
among
peptid
made
unsupervis
analysi
thu
antibodi
respons
pattern
reflect
close
peptid
sequenc
similar
supplementari
fig
base
previou
observ
antibodi
increas
specif
ntermin
portion
detect
serum
sampl
obtain
subject
rv
predicta
chip
equip
peptid
set
allow
detect
speciesspecif
immun
respons
high
resolut
fig
supplementari
figur
show
imag
rvspecif
antibodi
respons
measur
sera
six
repres
children
obtain
time
acut
episod
wheez
sera
followup
visit
month
later
sera
followup
visit
increas
antibodi
respons
rva
sera
rvc
sera
rvb
sera
peptid
could
detect
supplementari
fig
compar
peptidespecif
igg
antibodi
level
sera
obtain
children
time
acut
wheez
followup
month
later
ie
median
week
later
tabl
supplementari
figur
show
colorcod
map
peptidespecif
antibodi
respons
acut
phase
followup
children
demonstr
speciesspecif
igg
increas
next
compar
peptidespecif
increas
rel
number
child
fig
accord
peptidespecif
igg
increas
children
could
identifi
respond
preferenti
rvaderiv
peptid
n
rvcderiv
peptid
n
rvbderiv
peptid
n
mix
respons
pattern
n
fig
children
increas
peptidespecif
igg
respons
found
fig
bottom
analysi
perform
increas
antibodi
respons
complet
recombin
protein
three
rva
strain
ie
rvc
strain
yp
rvb
strain
fig
result
less
clear
neg
sever
children
strain
cover
recombin
protein
also
includ
fig
right
column
result
pcr
test
perform
use
primer
show
nucleic
acidbas
detect
viru
strain
neg
approxim
children
increas
rv
peptidespecif
igg
level
may
indic
higher
sensit
serolog
vs
pcr
children
moreov
pcr
result
correspond
well
specif
antibodi
respons
also
children
without
increas
rv
peptidespecif
antibodi
respons
posit
pcr
result
fig
bottom
figur
provid
summari
absolut
increas
peptidespecif
igg
respons
show
rva
rvcspecif
antibodi
respons
domin
rvbspecif
increas
next
investig
whether
antibodi
respons
certain
rv
speci
associ
sever
rvinduc
wheez
purpos
determin
number
day
respiratori
symptom
number
day
medic
requir
period
acut
followup
visit
number
day
respiratori
symptom
medic
significantli
higher
subject
increas
rva
mix
rvc
rvb
specif
signal
fig
top
middl
panel
analyz
sum
day
symptom
medic
found
rva
rvc
antibodi
increas
associ
highest
number
day
symptom
medic
fig
bottom
panel
children
rva
rvcspecif
antibodi
increas
significantli
day
symptom
medic
children
rvbspecif
antibodi
increas
fig
bottom
panel
within
european
unionfund
project
predicta
http
develop
predicta
chip
base
microarray
rvderiv
protein
peptid
select
repres
three
rv
speci
rva
rvb
rvc
use
predicta
chip
could
demonstr
cohort
preschool
children
acut
wheez
followup
visit
rvspecif
antibodi
respons
igg
iga
direct
ntermin
peptid
major
capsid
protein
confirm
earlier
result
obtain
map
antibodi
sinc
predicta
chip
design
contain
panel
synthet
peptid
repres
divers
rv
strain
three
genet
rv
speci
term
sequenc
ident
physicochem
properti
abl
perform
highresolut
map
rv
speciesspecif
antibodi
respons
serolog
cohort
clinic
welldescrib
swedish
preschool
children
sera
avail
episod
acut
wheez
requir
emerg
room
visit
followup
visit
convalesc
peptid
rva
rvc
speci
frequent
recogn
wherea
rvb
speci
much
less
commonli
recogn
interestingli
found
older
children
ie
children
older
year
age
recogn
peptid
rv
strain
younger
children
result
would
indic
children
encount
life
differ
rv
strain
thu
may
broaden
igg
reactiv
profil
later
life
need
confirm
longitudin
studi
sampl
taken
children
differ
age
recent
done
analysi
evolut
ige
reactiv
profil
allerg
children
birth
one
import
find
studi
could
demonstr
igg
reactiv
peptid
certain
rv
strain
increas
children
may
allow
identifi
culprit
rv
speci
respons
acut
wheez
serolog
furthermor
turn
increas
igg
respons
rva
rvc
speci
significantli
associ
sever
ill
compar
igg
increas
rvb
predicta
chip
thu
seem
suitabl
identifi
culprit
rv
speci
respons
exacerb
respiratori
ill
simpl
serolog
also
allow
determin
rv
speci
give
rise
sever
symptom
sinc
also
result
pcrbase
test
nasal
swab
sampl
children
could
compar
detect
strainspecif
nucleic
acid
antibodi
result
fact
found
children
without
speciesspecif
antibodi
increas
also
neg
pcr
test
howev
poor
correl
pcr
result
nasal
sampl
chipbas
serolog
result
furthermor
except
four
children
posit
pcr
result
obtain
followup
visit
pcr
result
neg
acut
followup
visit
approxim
children
speciesspecif
antibodi
increas
could
clearli
demonstr
sever
possibl
discrep
may
consid
exampl
may
possibl
time
interv
acut
infect
chosen
serolog
optim
howev
previous
investig
time
interv
requir
appear
antibodi
increas
control
infect
therefor
unlik
time
interv
use
studi
long
respons
discrep
pcr
test
serolog
also
think
crossreact
among
strain
origin
antigen
respons
observ
differ
taken
care
includ
chip
sequenc
sever
differ
rv
strain
result
fig
clearli
show
serolog
result
obtain
chip
allow
bona
fide
discrimin
rva
rvb
rvc
infect
use
larg
panel
rv
peptid
chip
final
found
older
children
recogn
rv
peptid
differ
strain
younger
children
fig
indic
children
develop
antibodi
new
virus
thu
concept
origin
antigen
sin
seem
appli
one
limit
studi
howev
exclud
infect
addit
rv
strain
occur
time
window
first
second
blood
sampl
thu
respons
discrep
pcr
result
serolog
nevertheless
think
discrep
pcr
result
serolog
rather
due
fact
everi
viru
detect
pcr
caus
infect
consecut
immun
respons
fact
studi
perform
young
children
report
asymptomat
subject
posit
pcr
one
like
possibl
poor
correl
pcr
result
antibodi
result
could
use
pcr
strategi
base
primer
specif
region
viral
genom
may
less
specif
pcr
strategi
base
amplif
sequenc
region
complet
rv
gener
nucleic
acidbas
strategi
viru
detect
demonstr
presenc
virusspecif
nucleic
acid
provid
evid
infect
taken
place
gave
rise
specif
immun
respons
therefor
think
predicta
chip
futur
version
contain
even
larger
repertoir
ntermin
peptid
rv
strain
complementari
tool
addit
pcr
test
eventu
turn
even
superior
antibodi
test
actual
fast
econom
take
hour
requir
microlit
amount
serum
furthermor
serolog
analysi
robust
easili
perform
without
need
pcr
cycler
subsequ
sequenc
howev
prospect
studi
need
investig
diagnost
sensit
specif
rv
chip
predicta
chip
may
extrem
use
determin
rv
speciesspecif
antibodi
respons
serum
sampl
exist
cohort
worldwid
defin
common
relev
rv
speci
involv
respiratori
ill
chipbas
measur
allow
explor
prospect
studi
role
rv
infect
varieti
respiratori
diseas
exacerb
exampl
possibl
discrimin
whether
asthma
exacerb
trigger
rv
infect
allergen
exposur
shown
factor
ie
rv
infect
well
allergen
exposur
induc
increas
specif
antibodi
respons
serum
sampl
collect
acut
visit
followup
visit
identif
culprit
factor
trigger
asthma
attack
becom
increasingli
import
respiratori
medicin
due
avail
select
treatment
allerg
asthma
antiig
antibodi
varieti
biolog
anticytokin
antibodi
target
differ
form
furthermor
possibl
use
predicta
chip
studi
serolog
analysi
possibl
contribut
rv
infect
exacerb
respiratori
diseas
copd
aco
studi
also
necessari
perform
multipl
monitor
presenc
rv
strain
respiratori
virus
pcr
immun
reaction
serolog
close
interv
extend
period
exacerb
reliabl
determin
common
rv
speci
involv
trigger
sever
respiratori
ill
ultim
provid
ration
basi
develop
rv
vaccin
rv
speciestarget
therapeut
conclus
develop
evalu
highresolut
antibodi
assay
base
microarray
peptid
recombin
antigen
common
rv
strain
identifi
antibodi
signatur
discrimin
rv
infect
level
differ
rv
speci
allow
point
toward
culprit
speci
respons
trigger
acut
preschool
wheez
predicta
chip
potenti
use
serolog
global
map
rv
infect
identif
rv
speci
involv
trigger
differ
form
sever
respiratori
ill
pave
road
rvspecif
therapeut
prophylact
treatment
strategi
vaccin
amino
acid
sequenc
rv
strain
repres
three
rv
speci
rva
n
rvb
n
rvc
n
retriev
ncbi
databas
http
wwwncbinlmnihgov
supplementari
tabl
multipl
sequenc
align
ntermin
peptid
aa
perform
use
softwar
avail
emblebi
websit
http
determin
amino
acid
sequenc
ident
among
peptid
peptid
sequenc
show
sequenc
ident
greater
ie
differ
aa
group
togeth
cluster
fig
sequenc
among
cluster
supplementari
tabl
realign
use
genedoc
softwar
http
iubiobioindianaedusoftmolbioibmpcgenedocreadmehtml
amino
acid
mismatch
analyz
regard
physicochem
properti
amino
acid
procedur
led
reclust
peptid
supplementari
tabl
reclust
group
one
repres
rv
strain
peptid
select
print
onto
chip
fig
supplementari
tabl
rva
n
rvb
n
rvc
n
enterovirusderiv
peptid
also
includ
fig
set
peptid
print
multipl
sequenc
align
perform
phylogenet
tree
construct
neighborjoin
nj
method
use
mega
softwar
wwwmegasoftwarenet
fig
evolutionari
distanc
sequenc
comput
use
kimura
model
bootstrap
valu
calcul
replic
addit
peptid
span
protein
fig
supplementari
tabl
select
detect
antibodi
toward
epitop
ntermin
portion
peptid
well
nonstructur
protein
strain
vpg
gpysgepkpksraperrvvtq
produc
solidphas
synthesi
carbonyl
fmoc
method
cemliberti
matthew
nc
usa
appli
biosystem
carlsbad
ca
usa
pegp
preload
resin
appli
biosystem
synthesi
peptid
wash
dichloromethan
cleav
resin
use
ml
trifluoroacet
acid
tfa
ml
silan
ml
precipit
prechil
tertbutylmethyleth
peptid
purifi
reversedphas
highperform
liquid
chromatographi
acetonitril
gradient
use
jupit
proteo
lc
column
phenomenex
torranc
ca
usa
ultim
pump
dionex
sunnyval
ca
usa
puriti
ident
molecular
weight
verifi
mass
spectrometri
microflex
malditof
bruker
billerica
usa
unsupervis
analysi
antibodi
respons
rv
peptid
protein
unsupervis
kmean
cluster
k
use
defin
cluster
peptid
similar
antibodi
respons
measur
k
number
cluster
predetermin
order
match
number
peptid
homolog
group
peptid
amino
acid
sequenc
align
gap
open
cost
gap
extens
cost
base
align
homolog
distanc
cladogram
built
use
neighborjoin
algorithm
bootstrap
replic
peptid
colorcod
base
antibodi
respons
cluster
belong
data
process
use
clc
genom
workbench
clc
clcbio
qiagen
hilden
germani
heat
map
repres
rvspecif
antibodi
respons
gener
qlucor
omic
explor
qlucor
lund
sweden
recombin
histag
structur
protein
five
repres
rv
strain
cyp
mbp
fusion
protein
contain
fragment
thereof
well
nonstructur
protein
rv
strain
express
escherichia
coli
previous
dna
sequenc
code
complet
gene
fragment
thereof
access
number
shown
supplementari
tabl
codon
optim
bacteri
express
synthes
addit
sequenc
code
ctermin
hexahistidin
tag
clone
ndei
ecori
site
plasmid
genscript
piscataway
nj
usa
transform
e
coli
cell
agil
technolog
santa
clara
ca
usa
induc
mm
iptg
cell
harvest
timepoint
maxim
express
recombin
protein
purifi
nickelaffin
chromatographi
denatur
condit
previous
describ
qiagen
hilden
germani
refold
recombin
protein
achiev
stepwis
dialysi
mm
structur
nonstructur
protein
mm
trishcl
mm
nacl
mm
edta
mbp
fusion
protein
respect
puriti
recombin
protein
verifi
sdspage
follow
coomassi
brilliant
blue
stain
ident
immunoblot
use
monoclon
mous
antihistag
antibodi
dilut
cat
dianova
hamburg
germani
bound
antibodi
detect
dilut
alkalin
phosphatasecoupl
rat
antimous
igg
antibodi
cat
bd
bioscienc
erembodegem
belgium
protein
concentr
determin
use
bca
protein
assay
kit
thermo
fisher
scientif
rockford
il
usa
secondari
structur
protein
measur
circular
dichroism
spectroscopi
jasko
spectropolarimet
japan
spectroscop
tokyo
japan
protein
concentr
mgml
mm
antihuigg
cat
jackson
immunoresearch
laboratori
west
grove
pa
usa
antihuiga
cat
becton
dickinson
franklin
lake
nj
label
dylight
pierc
thermo
fisher
scientif
rockford
il
usa
custom
print
rv
microarray
done
phadiathermofish
use
immunocap
isac
immuno
solidphas
allergen
chip
spot
perform
slow
pin
mode
print
use
aushon
printer
aushon
billerica
usa
stock
solut
peptid
mgml
dilut
phosphat
buffer
ph
use
spot
antigen
spot
triplic
glass
surfac
coat
aminoreact
organ
polym
spot
contain
fg
microarray
compon
correspond
attomol
allergen
use
calibr
control
protein
spot
microarray
list
supplementari
tabl
serum
sampl
examin
studi
cohort
preschool
children
admit
paediatr
emerg
ward
result
acut
wheez
astrid
lindgren
children
hospit
stockholm
sweden
tabl
cohort
genotyp
rv
strain
nasopharyng
swab
sampl
children
nest
pcr
sequenc
previous
molecular
diagnost
platform
rapid
detect
respiratori
strain
use
children
follow
respiratori
virus
found
adenoviru
children
bocaviru
children
coronaviru
children
influenza
ab
child
metapneumoviru
children
parainfluenzaviru
children
rsv
children
nasopharyng
swab
avail
rv
pcr
target
sequenc
written
inform
consent
obtain
parent
legal
guardian
studi
approv
region
ethic
committe
karolinska
institutet
stockholm
sweden
peripher
blood
sampl
obtain
within
h
present
emerg
unit
sera
store
addit
blood
sampl
nasopharyng
swab
sampl
obtain
acut
visit
followup
visit
research
nurs
store
biobank
depart
clinic
microbiolog
karolinska
univers
followup
sampl
obtain
week
initi
recruit
median
week
schedul
visit
recoveri
although
studi
plan
prospect
studi
assess
increas
rvspecif
antibodi
time
interv
week
suit
purpos
found
earlier
studi
increas
rvspecif
igg
respons
emerg
day
experiment
followup
visit
guardian
also
fill
standard
questionnair
concern
number
day
child
suffer
respiratori
symptom
home
ie
cough
andor
wheez
use
medic
ie
inhal
corticosteroid
leukotrien
receptor
antagonist
well
emerg
visit
acut
followup
visit
chip
analysi
anonym
sera
perform
approv
ethic
committe
medic
univers
vienna
microarray
wash
wash
buffer
phadiathermo
fisher
min
stir
dri
centrifug
min
g
rt
serum
sampl
appli
microarray
slide
incub
h
gentl
rock
rt
detect
rvspecif
igg
iga
antibodi
serum
sampl
dilut
sampl
dilut
buffer
phadiathermo
fisher
respect
microarray
rins
wash
buffer
wash
min
describ
centrifug
fluorescencelabel
antibodi
ad
slide
incub
min
gentl
rock
dark
rt
rins
wash
dri
microarray
scan
use
confoc
laser
scanner
microarray
scanner
capitalbio
beij
peopl
republ
china
imag
analysi
evalu
microarray
imag
analyz
softwar
phadiathermo
fisher
calibr
determin
background
signal
calibr
serum
ie
pool
allerg
patient
sera
dilut
sampl
diluent
includ
analysi
run
phadia
microarray
imag
analysi
softwar
use
process
imag
calcul
mean
fluoresc
intens
fi
triplic
analys
calibr
result
calibr
curv
gener
relat
fluoresc
intens
obtain
scan
predicta
microarray
allergenspecif
antibodi
level
measur
immunocap
result
report
isac
standard
unit
isu
background
reactiv
fluorescencelabel
antibodi
toward
microarray
compon
determin
test
six
replic
sampl
diluent
alon
character
assay
variabl
one
calibr
serum
three
normal
sera
profil
order
find
dilut
broadest
spectrum
reactiv
level
cover
assess
intraassay
ie
within
experi
variabl
six
replic
four
serum
sampl
use
measur
igg
reactiv
toward
microarray
compon
day
assess
interassay
ie
experi
variabl
four
serum
sampl
evalu
experi
conduct
five
consecut
day
evalu
four
differ
sampl
allow
determin
whether
interassay
variabl
sampledepend
microarray
compon
mean
isug
standard
deviat
sd
coeffici
variat
cv
sdmean
isug
across
six
replic
five
differ
experi
respect
calcul
sampl
microarray
compon
classifi
accord
isug
level
averag
across
compon
within
group
array
also
calcul
quantiti
initi
data
process
perform
microsoft
excel
frequenc
ie
number
reactiv
sera
intens
ie
isug
level
peptidespecif
igg
iga
antibodi
level
calcul
use
ibm
spss
statist
version
ibm
corp
armonk
ny
usa
median
valu
peptidespecif
igg
level
isug
calcul
use
graphpad
prism
la
jolla
ca
usa
cutoff
posit
igg
reactiv
set
isug
number
iggreact
peptid
fig
e
calcul
specif
igg
level
isug
increas
rvspecif
antibodi
respons
calcul
differ
isug
valu
measur
followup
f
acut
visit
isugf
isuga
follow
subtract
doubl
coeffici
variat
cv
calcul
baselin
valu
isuga
antigen
igg
level
isug
isug
determin
cv
intraassay
variabl
subtract
data
respect
rvspecif
igm
antibodi
measur
found
earlier
studi
increas
rvspecif
igm
antibodi
level
detect
day
experiment
rv
graphpad
prism
la
jolla
ca
usa
use
evalu
statist
paramet
correl
number
reactiv
peptid
age
evalu
calcul
spearman
rank
correl
coeffici
differ
group
number
reactiv
peptid
number
day
children
spent
respiratori
symptom
medic
use
assess
utest
twotail
valu
p
consid
statist
signific
primari
data
support
find
studi
avail
correspond
author
request
